Based on the results of the assessment of the company's corporate governance system for the of 12 month 2024 year: “LEADER FINANCE CAPITAL” i submitted a report on the assessment of the corporate department of the Company No. 21/02 dated fevral 13, 2025. According to the results of the evaluation of the corporate management system, the final number of points amounted to 1033 points, that is, 86,0 %, and according to “LEADER FINANCE CAPITAL”, the corporate control system in Biokimyo JSC according to the results of the 12 month of 2024 is recognized High" As a result of the study of the assessment of the corporate governance system, revealed: Notes on not following Codex recommendations Explanation II. Assessment of compliance with the recommendations of the Corporate Governance Code. clause 14. The composition of the Supervisory Board of JSC are not independent of the Supervisory Board The new composition of the Supervisory Board was elected at the extraordinary general meeting of shareholders on june 29, 2024, where independent candidates participated, but they did not receive the largest votes during the voting VII. Evaluation of information policy p.1.12, p.1.13, p.2.12, p.3.12. Completeness of disclosure of information on the JSC's website: p.1.12. Name of structural divisions, branches, representative offices, subsidiaries and dependent business entities, their phone numbers, addresses (postal and electronic), information about the order of their work; Item 1.31. video about the investment attractiveness of JSC Clause 1.12. The Company does not have structural divisions, branches, representative offices, subsidiaries and dependent business entities, in this regard, there is no information and information about them on the website; item 1.31. The main territory of the society is a categorized object, in this regard, videos are not published on the website, but videos of the media are published. VIII. Assessment of financial results p. 1-p.4. According to the results of the 12 month 2024 year, accounts receivable increased compared to the beginning of the reporting year. There is no overdue debt. The main reason for the increase in accounts receivable:advance payments for raw materials. Accounts payable increased compared to the beginning of the reporting year. There is no overdue debt. The main reason for the increase in creditworthiness is the accrued dividends of shareholders according to the decision of the annual General Meeting of Shareholders dated 06/18/2024.

1 November 2024

JSC "BIOKIMYO" announces that it will receive a commercial offer and a medical obsledovaniya sotrudnikov in November 2024.

14 October 2024

ATTENTION TO OWNERS OF PRIVATE APARTMENTS consuming heat energy supplied by JSC BIOKIMYO

14 September 2024

AJ «BIOKIMYO» announces the start of receiving applications for participation in the tender for the supply and installation of a turnkey solar power station On – GRID

Based on the results of the assessment of the company's corporate governance system for the of 6 month 2024 year:

reports on an extraordinary general meeting of shareholders JUNE 18, 2024 at 10-00 in a large hall of an administrative building JSC "Biokimyo"

About dividends

8 February 2024

To the attention of shareholders of Biokimyo JSC! Based on the decision of the meeting No. 5 of the Supervisory Board of the Company of febrary 5, 2024 reports on an extraordinary general meeting of shareholders Febrary 29, 2024 at 10-00 in a large hall of an administrative building JSC "Biokimyo" Address: city of Yangiyul, Kimyugar street, house 1.

26 October 2023

Based on the results of the assessment of the company's corporate governance system for the of 9 month 2023 year:

26 September 2023

MESSAGE on the acceptance of JSC “BIOKIMYO" recommendations Corporate Governance Rules

22 September 2023

Shareholders' Order of BIOKIMYO JSC dated September 19, 2023 Approved by the Extraordinary General Meeting Chairman of the Meeting O. Khurramov

Based on the decision of the meeting No. 2 of the Supervisory Board of the Company of August 23, 2023 reports on an extraordinary general meeting of shareholders September 19, 2023 at 10-00 in a large hall of an administrative building

ATTENTION TO SHAREHOLDERS OF JSC "BIOKIMYO"! According to the decisions of the General Meetings of Shareholders of BIOKIMYO JSC, dividends for 2019 - 2022 were accrued and paid in full and on time.

Based on the results of the assessment of the company's corporate governance system for the of 6 month 2023 yea